J.Safra Asset Management Corp Royalty Pharma PLC Transaction History
J.Safra Asset Management Corp
- $1.2 Billion
- Q4 2024
A detailed history of J.Safra Asset Management Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, J.Safra Asset Management Corp holds 26 shares of RPRX stock, worth $820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26
Previous 26
-0.0%
Holding current value
$820
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
433Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.25 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$726 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$536 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$446 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...